The Multi-Arm Multi-Stage Advantage: Transforming Multiple Sclerosis Trials
What if clinical trials could evaluate multiple treatment approaches at the same time and adapt as evidence emerges? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Jerem...
21 Syys 30min
Predicting MS: Can Data Bring Us Closer to Personalised Care?
Can growing amounts of real-world MS data help clinicians predict disease progression and make more personalised treatment decisions? In this episode of the ECTRIMS Podcast, host Brett Drummond speak...
27 Elo 31min
How Technology Is Transforming Multiple Sclerosis Care
Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of John...
12 Elo 31min
Should High-Risk Populations Be Screened for Multiple Sclerosis?
Could multiple sclerosis one day be detected before symptoms appear? And if so, should we be actively screening people who are at higher risk? In this episode of the ECTRIMS–MS Journal collaboration ...
30 Heinä 32min
How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey
Where someone lives can profoundly influence their multiple sclerosis journey. While advances in diagnosis and treatment have transformed MS care in many parts of the world, millions of people still f...
16 Heinä 27min
MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis
Welcome to MS Research Briefs, a new ECTRIMS podcast series delivering an expert guided tour of important new studies in multiple sclerosis research. In each episode, leading MS experts will take a sm...
2 Heinä 23min
Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation
Vitamin D and multiple sclerosis have been linked for decades, but how strong is the evidence – and what does it mean for clinical practice? In this episode of the ECTRIMS Podcast, host Brett Drummond...
18 Kesä 31min
